Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,commonStock,retainedEarnings,totalCurrentLiabilities,accountsPayable,totalAssets,cash,totalCurrentAssets,otherLiab,changeToLiabilities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,totalCashFromOperatingActivities,changeToNetincome,WC,language,region,quoteType,triggerable,quoteSourceName,currency,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,epsTrailingTwelveMonths,gmtOffSetMilliseconds,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,priceHint,shortName,longName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,marketState,exchange,market,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,esgPopulated,tradeable,exchangeDataDelayedBy,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry
t0,HSTC,-191163.0,5248580,,,-38740,,-38740,38304,0,-38304,-38304,,-436,,,,0,0,38304,0,-436,,-38740,-38740,5417236.0,191163.0,-191163.0,5249.0,-5613648.0,191163.0,158615.0,,,,,32222.0,5100.0,5100.0,758.0,-660.0,-5760.0,,,en-US,US,EQUITY,False,Delayed Quote,USD,0.0,0.1445 - 0.1445,0.1445,0.0,0.0,0,0,finmb_44789065,Other OTC,USD,445,278,0.0895,1.6272727,0.055 - 0.4,-0.25550002,-0.63875,0.055,0.4,1574726400,-0.044,-14400000,-0.029,0.11751389,0.026986115,0.22964191,0.10303169,0.041468315,4,HST GLOBAL INC,"HST Global, Inc.",0.1445,1630344268,0.0,0.1445,0.1445,0.1445,1063,PRE,PNK,us_market,0.40248117,758419,-4.982759,15,America/New_York,EDT,False,False,0,,,,0.4,0.055,0.1175,0.103,445,278,5.25M,,1.98M,53.40%,0.00%,,,,,,,,,,,0.00%,"Nov 25, 2019",,1:15,"Nov 25, 2019","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,,,,,,,,-212.9k,-0.0440,,,,31.1k,,,-0.03,-27.69k,,Value,23666,Healthcare,"HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.",Hampton,757 766 6100,VA,1609372800,United States,http://www.hstglobal.com,86400,150 Research Drive,Biotechnology
t-1,HSTC,-152423.0,5248580,,,-95197,,-95197,94657,0,-94657,-94657,,-540,,,,0,0,94657,0,-540,,-95197,-95197,5417236.0,153083.0,-152423.0,5249.0,-5574908.0,153083.0,4918.0,660.0,660.0,660.0,,4567.0,12476.0,12476.0,18064.0,-90.0,-12566.0,60000.0,-152423.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.0,0.1445 - 0.1445,0.1445,0.0,0.0,0,0,finmb_44789065,Other OTC,USD,445,278,0.0895,1.6272727,0.055 - 0.4,-0.25550002,-0.63875,0.055,0.4,1574726400,-0.044,-14400000,-0.029,0.11751389,0.026986115,0.22964191,0.10303169,0.041468315,4,HST GLOBAL INC,"HST Global, Inc.",0.1445,1630344268,0.0,0.1445,0.1445,0.1445,1063,PRE,PNK,us_market,0.40248117,758419,-4.982759,15,America/New_York,EDT,False,False,0,,,,0.4,0.055,0.1175,0.103,445,278,5.25M,,1.98M,53.40%,0.00%,,,,,,,,,,,0.00%,"Nov 25, 2019",,1:15,"Nov 25, 2019","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,,,,,,,,-212.9k,-0.0440,,,,31.1k,,,-0.03,-27.69k,,Value,23666,Healthcare,"HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.",Hampton,757 766 6100,VA,1609372800,United States,http://www.hstglobal.com,86400,150 Research Drive,Biotechnology
t-2,HSTC,-117225.0,5248580,,,-34934,,-34934,34682,0,-34682,-34682,,-252,,,,0,0,34682,0,-252,,-34934,-34934,5358236.0,117975.0,-117225.0,4248.0,-5479709.0,117975.0,1825.0,750.0,750.0,750.0,,-40.0,4000.0,4000.0,30252.0,-721.0,-4721.0,60000.0,-117225.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.0,0.1445 - 0.1445,0.1445,0.0,0.0,0,0,finmb_44789065,Other OTC,USD,445,278,0.0895,1.6272727,0.055 - 0.4,-0.25550002,-0.63875,0.055,0.4,1574726400,-0.044,-14400000,-0.029,0.11751389,0.026986115,0.22964191,0.10303169,0.041468315,4,HST GLOBAL INC,"HST Global, Inc.",0.1445,1630344268,0.0,0.1445,0.1445,0.1445,1063,PRE,PNK,us_market,0.40248117,758419,-4.982759,15,America/New_York,EDT,False,False,0,,,,0.4,0.055,0.1175,0.103,445,278,5.25M,,1.98M,53.40%,0.00%,,,,,,,,,,,0.00%,"Nov 25, 2019",,1:15,"Nov 25, 2019","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,,,,,,,,-212.9k,-0.0440,,,,31.1k,,,-0.03,-27.69k,,Value,23666,Healthcare,"HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.",Hampton,757 766 6100,VA,1609372800,United States,http://www.hstglobal.com,86400,150 Research Drive,Biotechnology
t-3,HSTC,-82293.0,5248580,,,-44028,,-44028,43822,0,-43822,-43822,,-206,,,,0,0,43822,0,-206,,-44028,-44028,5358236.0,83764.0,-82293.0,4248.0,-5444777.0,83763.0,1865.0,1471.0,1471.0,1471.0,1.0,-1180.0,9200.0,9200.0,37480.0,1471.0,-7729.0,60000.0,-82292.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.0,0.1445 - 0.1445,0.1445,0.0,0.0,0,0,finmb_44789065,Other OTC,USD,445,278,0.0895,1.6272727,0.055 - 0.4,-0.25550002,-0.63875,0.055,0.4,1574726400,-0.044,-14400000,-0.029,0.11751389,0.026986115,0.22964191,0.10303169,0.041468315,4,HST GLOBAL INC,"HST Global, Inc.",0.1445,1630344268,0.0,0.1445,0.1445,0.1445,1063,PRE,PNK,us_market,0.40248117,758419,-4.982759,15,America/New_York,EDT,False,False,0,,,,0.4,0.055,0.1175,0.103,445,278,5.25M,,1.98M,53.40%,0.00%,,,,,,,,,,,0.00%,"Nov 25, 2019",,1:15,"Nov 25, 2019","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,,,,,,,,-212.9k,-0.0440,,,,31.1k,,,-0.03,-27.69k,,Value,23666,Healthcare,"HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.",Hampton,757 766 6100,VA,1609372800,United States,http://www.hstglobal.com,86400,150 Research Drive,Biotechnology
